The American Society of Pain and Neuroscience (ASPN) has just issued UPDATED guidelines for physicians using neuromodulation ...

Raythera Inc. has identified TNF-α modulators reported to be useful for the treatment of inflammatory disorders, autoimmune disease, neurological disorders, pain, cardiovascular disorders, cancer, ...

Interventional neuroscience service provider Cutting Edge Health has formed a partnership with the mental wellness app Limitless Guided Visualizations, aiming to augment patient outcomes during ...

Biohaven Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases. The compounds are oral ...